Healthcare stocks have jumped into pricey territory. Anyone looking to buy in now might want to consider the laggards. The ...

What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in a large Phase 3 clinical trial? Who’s the iconoclastic outsider behind Summit ...

Here are 10 of the best health care stocks to buy in 2024, according to CFRA analysts: *As of Sept. 10 close. Based on ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Merck and Siemens have signed a strategic partnership to accelerate digital transformation in manufacturing through smart, ...

Merck & Co.’s best-selling drug Keytruda helped ... The findings, presented Sunday at the European Society for Medical Oncology Congress in Barcelona, show the initial benefits seen with ...

The FDA issued draft guidance on oncology clinical trials, taking the first steps toward formalizing a position that it's ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Joseph Romanelli, president, Human Health International, is scheduled to participate in a fireside chat at ...

Investorideas.com ( a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of cancer and solid tumors focusing on immunotherapy, ...